Announcements Trials
Browse Landscape

Phase

Phase 1 6Phase 2 5Phase 1/2 5Phase 3 3Phase 2/3 1

Status

Active not recruiting 4Recruiting 1

Sponsor Class

OTHER 4NIH 1

Study Type

Interventional 5

Sponsor

Cancer Type

Sarcoma 5

Conditions

Breast Neoplasms 222Carcinoma, Non-Small-Cell Lung 219Prostatic Neoplasms 156Multiple Myeloma 142Neoplasms 133Colorectal Neoplasms 118Leukemia, Myeloid, Acute 110Lung Neoplasms 103Neoplasm Metastasis 96Squamous Cell Carcinoma of Head and Neck 91Carcinoma, Hepatocellular 86Lymphoma 81Melanoma 78Pancreatic Neoplasms 74Triple Negative Breast Neoplasms 72Ovarian Neoplasms 66Sarcoma 65Lymphoma, Large B-Cell, Diffuse 61Carcinoma, Renal Cell 61Brain Neoplasms 58Precursor Cell Lymphoblastic Leukemia-Lymphoma 57Head and Neck Neoplasms 57Recurrence 56Lymphoma, Non-Hodgkin 55Stomach Neoplasms 53Leukemia, Lymphocytic, Chronic, B-Cell 52Hematologic Neoplasms 52Endometrial Neoplasms 50Small Cell Lung Carcinoma 48Urinary Bladder Neoplasms 46

Interventions

Magnetic Resonance Spectroscopy 2Immunoglobulin G 2talimogene laherparepvec 1ribociclib 1pembrolizumab 1palbociclib 1durvalumab 1cemiplimab 1Specimen Handling 1Radiotherapy 1Radiation 1Everolimus 1Disulfides 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Liposarcoma × 90 days × Clear all
NCT03114527 2026-05-22

Phase II Trial of Ribociclib and Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS)

Fox Chase Cancer Center

Phase 2 Active not recruiting
48 enrolled
Sarcoma

Leiomyosarcoma, Liposarcoma, Sarcoma

NCT07089992 2026-05-14

A Study of Pembrolizumab in People With Ultra-Rare Sarcomas

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
32 enrolled
Sarcoma

Liposarcoma, Sarcoma, Perivascular Epithelioid Cell Neoplasms

NCT02923778 2026-05-13

Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery

National Cancer Institute (NCI)

Phase 2 Active not recruiting
40 enrolled
Sarcoma

Leiomyosarcoma, Liposarcoma, Sarcoma, Histiocytoma, Malignant Fibrous

NCT05694871 2026-05-11

Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma

Alliance for Clinical Trials in Oncology

Phase 2 Active not recruiting
77 enrolled
Sarcoma

Liposarcoma

NCT04668300 2026-04-15

DOSa

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
75 enrolled
Sarcoma

Hemangiosarcoma, Liposarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡